VolitionRx Ltd Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2015

	Level 1		Level 2		Level 3		Fair Value at March 31, 2015
Liabilities
Derivative Liability	$	-	$	-	$	-	$	-

	Level 1		Level 2		Level 3		Fair Value at December 31, 2014
Liabilities
Derivative liability	$	-	$	1,577,640	$	-	$	1,577,640

Schedule of Derivative Liabilities at Fair Value

Balance as of December 31, 2014	$	1,577,640
Exercise of warrants attached to derivative liability	$	(74,347	)
Adjustment due to expiry of derivative liability	$	(1,163,549	)
Fair value adjustments	$	(339,744	)
Balance as of March 31, 2015	$	-

- Definition

Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.

+ References + Details